Avalo Therapeutics, Inc. Stock Forecast

Big movements in Avalo Therapeutics, Inc. stock price on Friday moving 12.36% between high and low
(Updated on May 17, 2024)

AVTX Signals & Forecast

There are few to no technical positive signals at the moment. The Avalo Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.48 and $13.91. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -55.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Avalo Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Avalo Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.10 between high and low, or 12.36%. For the last week, the stock has had daily average volatility of 8.93%.

Avalo Therapeutics, Inc. is oversold on RSI14 (3). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AVTX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Avalo Therapeutics, Inc. to open at $9.51, and during the day (based on 14 day Average True Range), to move between $7.95 and $11.23, which gives a possible trading interval of +/-$1.64 (+/-17.06%) up or down from last closing price. If Avalo Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 34.13% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $10.85, some $1.26 (13.14%) from the current price of $9.59, our system finds the risk reward not very attractive.

Is Avalo Therapeutics, Inc. stock A Buy?

The Avalo Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Avalo Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -4.349 Sell Candidate Downgraded

Predicted Opening Price for Avalo Therapeutics, Inc. of Monday, May 20, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.